MIDASOLVE
LIVE

Serial Number

79265537

Owner

Midatech Limited

Attorney

Manuel Valcarcel, Esq.

Filing Date

May 28, 2019

Add to watchlist:

No watchlists yet
View on USPTO

MIDASOLVE Trademark

Serial Number: 79265537 • Registration: 6235759

MIDASOLVE is a trademark filed by Midatech Limited on May 28, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Midatech Limited (9 trademarks)

Oddfellows House,

Entity Type: 99

Trademark Details

Filing Date

May 28, 2019

Registration Date

January 5, 2021

Published for Opposition

October 20, 2020

Goods & Services

Scientific research services in the field of nano-particle technology; pharmaceutical and drug research, development and discovery services; drug delivery agent research, development and discovery services; testing and advisory services related to research and product design in the field of nano-particles, macro-cyclic compounds, pharmaceuticals and nano-medicine; nano-particle laboratory research services

Nano-particle ingredients, namely, nanoparticle chemical compounds for use in the manufacture of pharmaceuticals, medicines and cosmetics; macrocylic chemicals used as solubilising and stabilising agents for use in manufacturing pharmaceuticals, medicines and cosmetics

Pharmaceuticals and medicines containing nano-particles for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immune system and central nervous system related diseases and disorders; vaccines incorporating nano-particles; drug delivery agents consisting of compounds that facilitate the delivery of pharmaceuticals and medicines; nano-particles for use as carriers sold as an integral component of pharmaceutical preparations and medicines for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immune system and central nervous system related diseases and disorders; nano-particles for use as carriers sold as an integral component of medicated cosmetics

Custom manufacture of nano-particles; custom manufacture of pharmaceuticals and medicines containing nano-particles; custom manufacture of nano-particle devices to the order and specification of others; custom manufacture of drug delivery agents for facilitating delivery of pharmaceuticals and medicines; custom manufacture of macrocylic compounds, compositions and derivates used as solubilising and stabilising agents for use in further manufacture of pharmaceuticals, medicines and cosmetics

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 5, 2026 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
May 2, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 12, 2021 FICS
FINAL DISPOSITION PROCESSED
Apr 12, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 5, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 5, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 20, 2020 NPUB
PUBLISHED FOR OPPOSITION
Oct 20, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Oct 18, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 30, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 30, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 30, 2020 NONP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Sep 18, 2020 ADCH
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 16, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 11, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 11, 2020 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sep 11, 2020 ERFR
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Mar 27, 2020 GNS1
SUBSEQUENT FINAL EMAILED
Mar 27, 2020 GNSF
SUBSEQUENT FINAL REFUSAL WRITTEN
Mar 27, 2020 CFRC
NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 26, 2020 GNFN
FINAL REFUSAL E-MAILED
Mar 26, 2020 GNFR
FINAL REFUSAL WRITTEN
Mar 26, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 12, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 12, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 12, 2020 TROA
REFUSAL PROCESSED BY IB
Oct 5, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 13, 2019 RFCS
REFUSAL PROCESSED BY MPU
Sep 13, 2019 RFRR
APPLICATION FILING RECEIPT MAILED
Sep 3, 2019 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 1, 2019 RFCR
NON-FINAL ACTION WRITTEN
Aug 31, 2019 CNRT
ASSIGNED TO EXAMINER
Aug 30, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 30, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 22, 2019 REPR